For example, TACIlo patients had clinical parameters associated with poor prognosis, such as an increase in the percentage of stage III MM, a decrease in hemoglobin level, and an increase in the percentage of bone lesions, suggesting that TACI expression level might be an independent prognostic factor for MM progression or disease severity. This evidence concerns the gene TNFRSF13B and Miyoshi myopathy.